Jonathan Feldschuh's most recent trade in Daxor Corp. was a trade of 25,000 Daxor Common Stock done . Disclosure was reported to the exchange on June 23, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Daxor Corp | Jonathan Feldschuh | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2026 | 25,000 | 78,908 (2%) | 0% | 0 | Daxor Common Stock | |
| Daxor Corp | Jonathan Feldschuh | Director, Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 09 Dec 2025 | 18,000 | 53,908 (1%) | 0% | 0 | Daxor Common Stock | |
| Daxor Corp | Jonathan Feldschuh | Director, Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 06 Dec 2024 | 32,000 | 35,908 (0%) | 0% | 0 | Daxor Common Stock | |
| Daxor Corp | Jonathan Feldschuh | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2023 | 25,000 | 25,000 | - | - | Stock Options (right to buy) |